Placental tissue grafts and improved methods of preparing and using the same
US-2016030633-A1 · Feb 4, 2016 · US
US11103536B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11103536-B2 |
| Application number | US-201916520909-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 24, 2019 |
| Priority date | Feb 14, 2011 |
| Publication date | Aug 31, 2021 |
| Grant date | Aug 31, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein are compositions composed of micronized placental components and pharmaceutical compositions thereof. The compositions have numerous medical applications. Methods for making and using the micronized compositions are also described herein.
Opening claim text (preview).
What is claimed: 1. A method for promoting wound healing, wherein the method comprises contacting a wound with a composition comprising micronized placental tissue particles, said tissue particles consisting essentially of an amnion layer and a chorion layer, wherein the chorion layer is layered directly over the amnion layer, wherein the intermediate layer has been substantially removed, wherein the amnion layer has an epithelial layer and an exposed fibroblast layer, and further wherein the wound healing is associated with an orthopedic application. 2. The method of claim 1 , wherein the orthopedic application is selected from the group consisting of tendon repair, aiding in the repair of periosteum, repair of ruptured/damaged bursa, securing void filling materials during bone repair, repair of an articular surface, repair of a soft-tissue injury in or around a joint, application to an articular surface, repair and/or regrow chondrocytes, and as an anti-adhesion barrier. 3. The method of claim 2 , wherein the soft-tissue injury is caused by trauma or repeated motion. 4. The method of claim 1 , wherein the micronized placental tissue particles are dehydrated. 5. The method of claim 1 , wherein the composition is an injectable composition. 6. The method of claim 1 , wherein the micronized placental tissue particles are less than 500 μm. 7. The method of claim 6 , wherein the micronized placental tissue particles are less than 300 μm. 8. The method of claim 7 , wherein the micronized placental tissue particles are 25-150 μm.
characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel · CPC title
Flowable or injectable implant compositions · CPC title
for soft tissue reconstruction · CPC title
characterised by the function or physical properties of the final product, where no specific conditions are defined to achieve this (A61L27/3687, A61L27/3691 take precedence) · CPC title
for treating wounds, ulcers, burns, scars, keloids, or the like · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.